Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.
about
Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models.Legal highs: staying on top of the flood of novel psychoactive substancesToxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literatureRecent advances in the neuropsychopharmacology of serotonergic hallucinogensNPS: Medical Consequences Associated with Their IntakePsychedelicsNBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System.Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample.Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice."My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion.N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects.Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines.Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.Analysis of 25 C NBOMe in Seized Blotters by HPTLC and GC-MS.Effect of Hallucinogens on Unconditioned Behavior.Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).Detection of 25C-NBOMe in Three Related Cases.Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice.Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening powComparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers
P2860
Q26752605-3300C63C-887B-4B8B-ABDE-BE3366DA2583Q26799231-46BE6A1D-7D10-4E21-9D0F-99645AE257A8Q26865329-D79A2196-D795-4A41-898D-A578104A084EQ27027381-FB1E3BC4-091C-4AFC-AA13-15F5D7BE0287Q28276182-75CAFB44-7577-4B47-83EA-FEA89F30EB0FQ30359998-C139485F-EAF4-416A-9FC8-818624A31EC1Q30969880-C211D2E5-D92E-401E-947C-29199CD5C53CQ34396223-8A65091A-2EBE-4CDD-8B9F-74119801F53DQ34406732-1677A5F1-0429-4EC5-AC0F-BAA406C18E17Q34438870-EC900A77-620F-41A0-B1C1-C87FBE53ED19Q34453002-D5E486C1-16DE-4748-8E84-826E85DF9431Q34455931-7AE1BA51-CD79-401B-958E-6678D4F0E538Q34497649-6A17B650-6DBB-46CB-8350-6D89AD780C3DQ37331831-3E86A4B6-E424-4E54-983B-E0F7BC9E71ADQ38208426-5A189910-D47B-4112-9ACE-433DF2B1128DQ39093171-A31579CF-F127-4E7D-956E-EC9837B34BF0Q40694962-E188FE68-DC4F-49A9-80BD-8775F091ECABQ42025447-B3CABC74-056D-4AA8-896E-2FF21E747324Q42156143-9E07A588-972F-4163-9538-00BD202A0E2CQ45279141-3E6DE431-3DD1-4DF5-A9B8-FE3EC4DECDDEQ46573497-E307F2E4-E155-432A-9854-B3F826C5FF27Q48721685-2AD7CCAB-0E56-4B6F-B24F-E6E7A5A88B77Q50257597-0B300ADD-516E-4D7B-A057-C18A27C0BF08Q50673261-1442CF26-624B-4781-9B97-976736109EEDQ52760538-E8910106-03E8-499E-A2C3-3CF9C6E37705Q53080749-50B26624-A6B2-4AA0-B74B-CDED1428370FQ59218493-66C4F32C-0BD7-4BDF-BE19-3E506D9C038B
P2860
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effects of the hallucinogen 2, ...... s on the head twitch response.
@ast
Effects of the hallucinogen 2, ...... s on the head twitch response.
@en
Effects of the hallucinogen 2, ...... s on the head twitch response.
@nl
type
label
Effects of the hallucinogen 2, ...... s on the head twitch response.
@ast
Effects of the hallucinogen 2, ...... s on the head twitch response.
@en
Effects of the hallucinogen 2, ...... s on the head twitch response.
@nl
prefLabel
Effects of the hallucinogen 2, ...... s on the head twitch response.
@ast
Effects of the hallucinogen 2, ...... s on the head twitch response.
@en
Effects of the hallucinogen 2, ...... s on the head twitch response.
@nl
P2860
P1433
P1476
Effects of the hallucinogen 2, ...... s on the head twitch response.
@en
P2093
Adam L Halberstadt
Mark A Geyer
P2860
P304
P356
10.1016/J.NEUROPHARM.2013.08.025
P577
2013-09-04T00:00:00Z